cas ?86386-73-4 ?99% fluconazole ?powder

Details:

cas  86386-73-4  99% fluconazole  powder 

Product Name:   Fluconazole
CAS:    86386-73-4
MF:    C13H12F2N6O
MW:    306.27
EINECS:    627-806-0

 Fluconazole  is a novel kind triazole drug of anti-fungal infection   with broad-spectrum anti-fungal effect. It belongs to a kind of systemic anti-fungal products and has high selectivity on the inhibitory effect of the fungal cytochrome P450-dependent enzyme. It is also a kind of potent and specific inhibitor for the fungi alcohol synthesis. Clinically it is mainly used for the treatment of vaginal candidiasis, thrush, atrophic oral candidiasis, fungal meningitis, pulmonary fungal infections, abdominal infections, urinary tract infections and skin fungi infection.

 Fluconazole function
1. Fluconazole is indicated in the treatment of febrile neutropenia when fungal infections are suspected or proven. 
2. Fluconazole is indicated in nonimmunocompromised patients for the treatment of onychomycosis caused by tinea unguium, Trichophyton species and Candida species. 
3. Fluconazole is indicated for the treatment and suppression of cryptococcal meningitis. 
4. Fluconazole is indicated in the treatment of pulmonary and disseminated coccidioidomycosis caused by Coccidioides immitis.
5. Fluconazole is indicated in the treatment of vulvovaginal candidiasis caused by Candida species. 
6. Fluconazole is indicated for the treatment of serious infections, including peritonitis, pneumonia, and urinary tract infections, caused by susceptible Candida species. 
7. Fluconazole is also indicated for the treatment of systemic infections caused by Candida species in neonates. 
8. Fluconazole is indicated for the treatment of esophageal and oropharyngeal candidiasis (thrush) caused by Candida species.
9. Fluconazole is indicated for the prophylaxis of candidiasis in patients undergoing bone marrow transplant who receive cytotoxic chemotherapy and/or radiation therapy.